Is Survodutide legal in Texas?
status · caveats apply
Investigational GLP-1/glucagon dual agonist; FDA Breakthrough Therapy + Fast Track for MASH; no approval; class-effect WADA S2 prohibition. No state-level peptide restrictions beyond federal law in Texas.
category: investigational · last verified May 13, 2026
§ 01
Quick answer
Investigational GLP-1/glucagon dual agonist; FDA Breakthrough Therapy + Fast Track for MASH; no approval; class-effect WADA S2 prohibition. No state-level peptide restrictions beyond federal law in Texas.
§ 02
Full status breakdown
Federal status
FDA approval
DEA scheduling
not scheduled
503A compounding
Bulks list: not on list
Do-not-compound list: not on list
Never nominated for 503A bulks list.
FDA Warning Letters
none on record for this compound
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: As an unapproved investigational drug, commercial sale outside a sponsored clinical trial is an FDCA §505 violation. RUO disclaimers do not cure this where downstream human use is foreseeable.
Personal possession: Not federally criminalized.
Texas — state-specific
Sport-body status
WADA 2026
on prohibited list · class S2 · both
Captured by GLP-1 agonist + glucagon receptor class language (no explicit naming).
USADA
unknown
NCAA
unknown
What we couldn’t verify
§ 03
Also known as
Survodutide is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):
BI 456906GLP-1/glucagon dual agonistBoehringer Ingelheim survodutide
§ 04
Disclaimer
§ 05
Related
- Back to peptide legality lookup — pick a different compound or state
- Peptide pricing index — what each compound costs per mg across audited vendors
- Janoshik COA verifier — a separate question from legality: does the COA the vendor cites actually exist?
the roundup · monthly
Receipts in your inbox. Once a month.
New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.
14,200 subscribers· 0 sponsored items· 11 issues since launch